Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (61812) 61812
Publication (5029) 5029
Book Review (771) 771
Book Chapter (561) 561
Conference Proceeding (61) 61
Magazine Article (39) 39
Book / eBook (38) 38
Dissertation (34) 34
Newsletter (18) 18
Paper (12) 12
Data Set (9) 9
Web Resource (6) 6
Presentation (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47216) 47216
male (31665) 31665
cardiac & cardiovascular systems (31276) 31276
index medicus (30386) 30386
female (28144) 28144
middle aged (21147) 21147
aged (16955) 16955
heart failure (14051) 14051
adult (11377) 11377
echocardiography (11061) 11061
animals (10500) 10500
treatment outcome (9823) 9823
mortality (9088) 9088
risk factors (8419) 8419
heart (8338) 8338
cardiology (8262) 8262
prognosis (7545) 7545
cardiovascular (6846) 6846
heart-failure (6798) 6798
heart failure - physiopathology (6649) 6649
electrocardiography (6339) 6339
left-ventricular dysfunction (6262) 6262
ventricular dysfunction, left - physiopathology (6240) 6240
care and treatment (5847) 5847
time factors (5735) 5735
follow-up studies (5585) 5585
medicine & public health (5436) 5436
cardiomyopathy (5340) 5340
cardiac patients (5224) 5224
ventricular function, left (5028) 5028
prospective studies (4940) 4940
stroke volume (4922) 4922
hypertension (4896) 4896
analysis (4858) 4858
retrospective studies (4608) 4608
dysfunction (4600) 4600
myocardial-infarction (4399) 4399
surgery (4287) 4287
peripheral vascular disease (4232) 4232
heart failure - therapy (4199) 4199
abridged index medicus (4179) 4179
aged, 80 and over (4152) 4152
therapy (3990) 3990
heart diseases (3919) 3919
ventricular dysfunction, left - diagnostic imaging (3909) 3909
heart failure - drug therapy (3891) 3891
acute myocardial-infarction (3867) 3867
diagnosis (3835) 3835
heart attacks (3707) 3707
rats (3691) 3691
ventricular dysfunction, left - etiology (3688) 3688
disease (3644) 3644
health aspects (3625) 3625
survival (3609) 3609
predictive value of tests (3489) 3489
research (3475) 3475
myocardial infarction (3380) 3380
cardiovascular disease (3355) 3355
pharmacology & pharmacy (3260) 3260
myocardial infarction - physiopathology (3259) 3259
ventricular function, left - physiology (3231) 3231
dilated cardiomyopathy (3178) 3178
respiratory system (3119) 3119
medicine, general & internal (3073) 3073
myocardium - pathology (3042) 3042
adolescent (3020) 3020
hemodynamics (2986) 2986
transplantation (2929) 2929
disease models, animal (2886) 2886
severity of illness index (2822) 2822
left-ventricular function (2791) 2791
ventricular dysfunction, left - therapy (2781) 2781
cardiovascular diseases (2718) 2718
risk assessment (2716) 2716
congestive-heart-failure (2713) 2713
blood pressure (2670) 2670
risk (2664) 2664
left-ventricular hypertrophy (2652) 2652
ventricular dysfunction, left - diagnosis (2619) 2619
cardiac resynchronization therapy (2613) 2613
radiology, nuclear medicine & medical imaging (2594) 2594
ejection fraction (2564) 2564
ventricular function, left - drug effects (2557) 2557
article (2525) 2525
heart failure - diagnosis (2488) 2488
cardiology and cardiovascular medicine (2481) 2481
cardiovascular system (2476) 2476
heart ventricles - physiopathology (2474) 2474
heart failure - etiology (2469) 2469
angiotensin-converting enzyme inhibitors - therapeutic use (2438) 2438
heart failure - mortality (2423) 2423
heart attack (2415) 2415
drug therapy (2370) 2370
child (2357) 2357
ventricle (2346) 2346
patients (2321) 2321
magnetic resonance imaging (2310) 2310
sensitivity and specificity (2305) 2305
hypertrophy (2303) 2303
stroke volume - physiology (2299) 2299
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (19) 19
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Circulation Desk (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (60287) 60287
German (621) 621
Russian (320) 320
French (302) 302
Spanish (225) 225
Polish (138) 138
Italian (133) 133
Japanese (97) 97
Portuguese (81) 81
Chinese (55) 55
Turkish (42) 42
Czech (32) 32
Dutch (20) 20
Hungarian (18) 18
Norwegian (13) 13
Ukrainian (12) 12
Danish (11) 11
Korean (11) 11
Lithuanian (7) 7
Serbian (7) 7
Swedish (5) 5
Finnish (4) 4
Hebrew (4) 4
Arabic (2) 2
Croatian (2) 2
Romanian (2) 2
Slovak (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes
by Seferovic, P.M and Paulus, W.J
European Heart Journal, ISSN 0195-668X, 2015, Volume 36, Issue 27, pp. 1718 - 1728
Diabetes mellitus-related cardiomyopathy (DMCMP) was originally described as a dilated phenotype with eccentric left ventricular (LV) remodelling and systolic... 
Heart failure | Diabetic cardiomyopathy | Diastolic dysfunction | Left ventricular Remodelling | Diabetes mellitus | CARDIAC-FUNCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | ENDOTHELIAL DYSFUNCTION | DIASTOLIC FUNCTION | PRESERVED EJECTION FRACTION | MYOCARDIAL SUBSTRATE METABOLISM | EUROPEAN-SOCIETY | HYPERTENSIVE PATIENTS | CROSS-LINK BREAKER | CONGESTIVE-HEART-FAILURE | GLYCATION END-PRODUCTS | Hypoglycemic Agents - therapeutic use | Diabetic Cardiomyopathies - etiology | Risk Reduction Behavior | Ventricular Dysfunction - therapy | Humans | Cardiomyopathy, Restrictive - diagnosis | Ventricular Dysfunction - etiology | Cardiomyopathy, Restrictive - etiology | Diabetic Cardiomyopathies - diagnosis | Autoimmunity - physiology | Cardiomyopathy, Restrictive - therapy | Heart Failure - therapy | Phenotype | Ventricular Dysfunction - diagnosis | Cardiomyopathy, Dilated - etiology | Insulin Resistance - physiology | Glycation End Products, Advanced - metabolism | Cardiomyopathy, Dilated - diagnosis | Diabetic Cardiomyopathies - therapy | Heart Failure - diagnosis | Hyperglycemia - etiology | Heart Failure - etiology | Cardiomyopathy, Dilated - therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction. Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Trial
by Daubert, Claude and Gold, Michael R and Abraham, William T and Ghio, Stefano and Hassager, Christian and Goode, Grahame and Szili-Török, Tamás and Linde, Cecilia and REVERSE Study Grp and REVERSE Study Group
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2009, Volume 54, Issue 20, pp. 1837 - 1846
Objectives: The aim of this study was to determine the long-term effects of cardiac resynchronization therapy (CRT) in the European cohort of patients enrolled... 
heart failure | reverse cardiac remodeling | cardiac resynchronization therapy | biventricular stimulation | randomized controlled trial | MORTALITY | CHRONIC HEART-FAILURE | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | RATIONALE | INTRAVENTRICULAR-CONDUCTION DELAY | CARE-HF TRIAL | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | Prospective Studies | Defibrillators, Implantable - adverse effects | Follow-Up Studies | Humans | Middle Aged | Europe - epidemiology | Hospitalization - statistics & numerical data | Male | Treatment Outcome | Ventricular Dysfunction, Left - mortality | Cardiac Pacing, Artificial - adverse effects | Disease Progression | Heart Failure - prevention & control | Ventricular Dysfunction, Left - therapy | Ventricular Remodeling | Female | Aged | Heart rate | Heart failure | Enzymes | Body mass index | Ultrasonic imaging | Heart attacks | Cardiomyopathy | Mortality | Questionnaires | Cardiovascular disease | Hospitalization | Drug therapy | Bioengineering | Ventricular Dysfunction, Left | Europe | Cardiac Pacing, Artificial | Signal and Image processing | Life Sciences | Human health and pathology | Defibrillators, Implantable | Computer Science | Heart Failure | Engineering Sciences | Cardiology and cardiovascular system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging
by Bloom, Michelle W and Hamo, Carine E and Cardinale, Daniela and Ky, Bonnie and Nohria, Anju and Baer, Lea and Skopicki, Hal and Lenihan, Daniel J and Gheorghiade, Mihai and Lyon, Alexander R and Butler, Javed
Circulation: Heart Failure, ISSN 1941-3289, 01/2016, Volume 9, Issue 1, pp. e002661 - e002661
Advances in cancer therapy have resulted in significant improvement in long-term survival for many types of cancer but have also resulted in untoward side... 
trastuzumab | heart failure | Anthracyclines | cardiotoxicity | ventricular dysfunction, left | cardiomyopathies | chemotherapy | VENTRICULAR EJECTION FRACTION | ADJUVANT CHEMOTHERAPY | LONG-TERM SURVIVORS | CARDIAC & CARDIOVASCULAR SYSTEMS | TRASTUZUMAB-INDUCED CARDIOTOXICITY | ventricular dysfunction | EUROPEAN ASSOCIATION | HER2-POSITIVE BREAST-CANCER | RENAL-CELL CARCINOMA | TROPONIN-I | left | anthracyclines | HIGH-DOSE CHEMOTHERAPY | AMERICAN-SOCIETY | Predictive Value of Tests | Prognosis | Humans | Heart Failure - physiopathology | Radiotherapy - adverse effects | Diagnostic Imaging - methods | Cardiomyopathies - physiopathology | Time Factors | Antineoplastic Agents - adverse effects | Cardiomyopathies - diagnosis | Neoplasms - radiotherapy | Heart Failure - diagnosis | Heart Failure - epidemiology | Risk Assessment | Comorbidity | Risk Factors | Radiation Injuries - diagnosis | Terminology as Topic | Treatment Outcome | Biomarkers - blood | Neoplasms - drug therapy | Radiation Injuries - epidemiology | Cardiomyopathies - epidemiology | Radiation Injuries - physiopathology | Heart Failure - chemically induced | Cardiomyopathies - chemically induced | treatment | cancer therapy | anthracycline | left ventricular dysfunction | cardiomyopathy | left ventricular ejection fraction
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction: A Systematic Review
by McAlister, Finlay A and Ezekowitz, Justin and Hooton, Nicola and Vandermeer, Ben and Spooner, Carol and Dryden, Donna M and Page, Richard L and Hlatky, Mark A and Rowe, Brian H
JAMA, ISSN 0098-7484, 06/2007, Volume 297, Issue 22, pp. 2502 - 2514
CONTEXT Left ventricular (LV) systolic dysfunction causes substantial morbidity and mortality, even with optimal pharmacotherapy. Atrial-synchronized... 
RANDOMIZED CONTROLLED-TRIALS | MEDICINE, GENERAL & INTERNAL | CORONARY-SINUS | COST-EFFECTIVENESS | CARE-HF TRIAL | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | INTRAVENTRICULAR-CONDUCTION DELAY | CHRONIC ATRIAL-FIBRILLATION | TERM-FOLLOW-UP | CONGESTIVE-HEART-FAILURE | RESYNCHRONISATION THERAPY | Ventricular Dysfunction, Left - therapy | Treatment Outcome | Systole | Defibrillators, Implantable | Humans | Pacemaker, Artificial | Care and treatment | Heart diseases | Cardiac patients | Patient outcomes | Cardiovascular system | Medical equipment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Cancer therapy-related cardiac dysfunction and heart failure: Part 2: Prevention, treatment, guidelines, and future directions
by Hamo, Carine E and Bloom, Michelle W and Cardinale, Daniela and Ky, Bonnie and Nohria, Anju and Baer, Lea and Skopicki, Hal and Lenihan, Daniel J and Gheorghiade, Mihai and Lyon, Alexander R and Butler, Javed
Circulation: Heart Failure, ISSN 1941-3289, 02/2016, Volume 9, Issue 2, pp. 1 - 10
Success with oncologic treatment has allowed cancer patients to experience longer cancer-free survival gains. Unfortunately, this success has been tempered by... 
Heart | Heart failure | Cardiomyopathies | Cardiotoxicity | Trastuzumab | VENTRICULAR SYSTOLIC DYSFUNCTION | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | FOLLOW-UP | EUROPEAN ASSOCIATION | heart | CHEMOTHERAPY-INDUCED CARDIOMYOPATHY | trastuzumab | BREAST-CANCER | cardiotoxicity | INDUCED CARDIOTOXICITY | ANTHRACYCLINE-INDUCED CARDIOMYOPATHY | ASSOCIATION TASK-FORCE | cardiomyopathies | EXPERT CONSENSUS | AMERICAN-SOCIETY | Predictive Value of Tests | Humans | Heart Failure - physiopathology | Cardiomyopathies - prevention & control | Ventricular Dysfunction, Left - chemically induced | Heart Failure - prevention & control | Heart Failure - therapy | Ventricular Dysfunction, Left - therapy | Cardiomyopathies - physiopathology | Antineoplastic Agents - adverse effects | Cardiomyopathies - diagnosis | Heart Failure - diagnosis | Risk Factors | Ventricular Function, Left - drug effects | Treatment Outcome | Ventricular Dysfunction, Left - diagnosis | Critical Pathways | Ventricular Dysfunction, Left - physiopathology | Ventricular Dysfunction, Left - prevention & control | Cardiomyopathies - therapy | Algorithms | Animals | Heart Failure - chemically induced | Cardiomyopathies - chemically induced | Practice Guidelines as Topic | cancer therapy | anthracycline | cardiomyopathy | chemotherapy | cardiac failure
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure
by Yu, Cheuk-Man and Chau, Elaine and Sanderson, John E and Fan, Katherine and Tang, Man-Oi and Fung, Wing-Hong and Lin, Hong and Kong, Shun-Ling and Lam, Yui-Ming and Hill, Michael R. S and Lau, Chu-Pak
Circulation, ISSN 0009-7322, 01/2002, Volume 105, Issue 4, pp. 438 - 445
Background-Biventricular pacing has been proposed to improve symptoms and exercise capacity in patients with advanced heart failure and wide... 
Heart failure | Pacing | Echocardiography | Pacemakers | pacemakers | SURVIVAL | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | INSYNC | echocardiography | VALIDATION | DILATED CARDIOMYOPATHY | CONDUCTION DELAY | pacing | PATTERN | PERIPHERAL VASCULAR DISEASE | DYSFUNCTION | HEMATOLOGY | Myocardial Contraction | Models, Cardiovascular | Ventricular Dysfunction - therapy | Humans | Heart Failure - physiopathology | Periodicity | Male | Cardiac Pacing, Artificial - methods | Ventricular Dysfunction, Left - diagnostic imaging | Ventricular Dysfunction, Left - physiopathology | Heart Failure - therapy | Ventricular Dysfunction, Left - therapy | Ventricular Remodeling | Heart Ventricles - physiopathology | Ventricular Dysfunction - diagnostic imaging | Echocardiography, Doppler - methods | Female | Aged | Heart Failure - diagnostic imaging | Hemodynamics | Kinetics | Ventricular Dysfunction - physiopathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Delayed Enhancement Magnetic Resonance Imaging Predicts Response to Cardiac Resynchronization Therapy in Patients With Intraventricular Dyssynchrony
by White, James A and Yee, Raymond and Yuan, Xiaping and Krahn, Andrew and Skanes, Allan and Parker, Michele and Klein, George and Drangova, Maria
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2006, Volume 48, Issue 10, pp. 1953 - 1960
Delayed Enhancement Magnetic Resonance Imaging Predicts Response to Cardiac Resynchronization Therapy in Patients With Intraventricular Dyssynchrony James A.... 
CHRONIC HEART-FAILURE | LEFT-VENTRICULAR DYSSYNCHRONY | INFARCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | CONDUCTION DELAY | STIMULATION | IDIOPATHIC DILATED CARDIOMYOPATHY | TISSUE | REVERSIBLE MYOCARDIAL DYSFUNCTION | ECHOCARDIOGRAPHY | STRAIN | Predictive Value of Tests | Cicatrix - etiology | Image Enhancement | Humans | Middle Aged | Male | Cicatrix - diagnosis | Systole | Time Factors | Female | Echocardiography | Ventricular Dysfunction - complications | Ventricular Dysfunction - therapy | Medical Records | Treatment Outcome | Cardiac Output, Low - physiopathology | Cardiac Pacing, Artificial | Cardiac Output, Low - complications | Magnetic Resonance Imaging | Myocardial Infarction - complications | Ventricular Dysfunction - diagnosis | Ventricular Dysfunction - diagnostic imaging | Cardiac Output, Low - diagnosis | Cardiac Output, Low - therapy | Aged | Heart failure | Medicine, Experimental | Medical research | Magnetic resonance imaging | Cardiology | Cardiac patients | Research institutes | Heart attacks | Nuclear magnetic resonance--NMR | Drug therapy | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study
by Prabhu, Sandeep and Taylor, Andrew J and Costello, Ben T and Kaye, David M and McLellan, Alex J.A and Voskoboinik, Aleksandr and Sugumar, Hariharan and Lockwood, Siobhan M and Stokes, Michael B and Pathik, Bhupesh and Nalliah, Chrishan J and Wong, Geoff R and Azzopardi, Sonia M and Gutman, Sarah J and Lee, Geoffrey and Layland, Jamie and Mariani, Justin A and Ling, Liang-han and Kalman, Jonathan M and Kistler, Peter M
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2017, Volume 70, Issue 16, pp. 1949 - 1961
Background Atrial fibrillation (AF) and left ventricular systolic dysfunction (LVSD) frequently co-exist despite adequate rate control. Existing randomized... 
persistent AF | medical rate control | catheter ablation | late gadolinium enhancement | idiopathic cardiomyopathy | FIBROSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | IDIOPATHIC DILATED CARDIOMYOPATHY | TRIAL | IMPACT | DISEASE | PULMONARY-VEIN ISOLATION | CONGESTIVE-HEART-FAILURE | EPIDEMIOLOGY | Gadolinium - administration & dosage | Single-Blind Method | Ventricular Dysfunction, Left - epidemiology | Prospective Studies | Catheter Ablation - trends | Atrial Fibrillation - therapy | Humans | Middle Aged | Electrocardiography, Ambulatory - methods | Electrocardiography, Ambulatory - trends | Male | Ventricular Dysfunction, Left - diagnostic imaging | Magnetic Resonance Imaging, Cine - trends | Catheter Ablation - methods | Ventricular Dysfunction, Left - therapy | Magnetic Resonance Imaging, Cine - methods | Atrial Fibrillation - diagnostic imaging | Atrial Fibrillation - epidemiology | Female | Aged | Ablation (Surgery) | Analysis | Atrial fibrillation | Cardiac arrhythmia | Nuclear magnetic resonance--NMR | Cardiomyopathy | Gadolinium | Cardiovascular disease | Optimization | Randomization | Fibrillation | Motivation | Restoration | Etiology | Adequacy | Sinus | Electrocardiography | Heart diseases | Medical instruments | Rhythm | Patients | Ablation | Catheters | Heart rate | Magnetic resonance imaging | Fibrosis | Ventricle | Ejection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: Results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) study
by Gold, Michael R and Thébault, Christophe and Linde, Cecilia and Abraham, William T and Gerritse, Bart and Ghio, Stefano and St. John Sutton, Martin and Daubert, Jean-Claude
Circulation, ISSN 0009-7322, 08/2012, Volume 126, Issue 7, pp. 822 - 829
Background-Cardiac resynchronization therapy (CRT) decreases mortality, improves functional status, and induces reverse left ventricular remodeling in selected... 
bundle-branch block | heart failure | pacing | cardiomyopathy | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | GUIDELINES | COMMITTEE | EUROPEAN-SOCIETY | TRIAL | ELECTROCARDIOGRAPHY | RECOMMENDATIONS | PERIPHERAL VASCULAR DISEASE | INTRAVENTRICULAR-CONDUCTION DISTURBANCES | ASSOCIATION | Heart - physiopathology | Severity of Illness Index | Bundle-Branch Block - complications | Humans | Middle Aged | Male | Treatment Outcome | Ventricular Remodeling - physiology | Ventricular Dysfunction, Left - physiopathology | Heart Failure - therapy | Ventricular Dysfunction, Left - therapy | Myocardial Ischemia - complications | Electrocardiography | Female | Aged | Cardiac Resynchronization Therapy | Heart Failure - etiology | Heart | Bioengineering | Ventricular Dysfunction, Left | Myocardial Ischemia | Bundle-Branch Block | Life Sciences | Human health and pathology | Ventricular Remodeling | Heart Failure | Cardiology and cardiovascular system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Biomarkers in cancer therapy related cardiac dysfunction (CTRCD)
by Moudgil, Rohit and Parekh, Parag A
Heart Failure Reviews, ISSN 1382-4147, 3/2018, Volume 23, Issue 2, pp. 255 - 259
Biomarkers are at the cornerstone of preventive measures and contribute to the screening process. More recently, biomarkers have been used to gauge the... 
Heart failure | Biomarkers | Medicine & Public Health | Cancer therapy related cardiac dysfunction (CTRCD) | Cardiology | VENTRICULAR EJECTION FRACTION | CARDIAC & CARDIOVASCULAR SYSTEMS | BRAIN NATRIURETIC PEPTIDE | PULMONARY ARTERIAL-HYPERTENSION | HEART-FAILURE | CELL TRANSPLANTATION | TROPONIN-I | BREAST-CANCER | CARDIOVASCULAR-DISEASE | ANTHRACYCLINE-INDUCED CARDIOTOXICITY | HIGH-DOSE CHEMOTHERAPY | Heart Failure - complications | Neoplasms - blood | Antineoplastic Agents - adverse effects | Humans | Heart Failure - physiopathology | Stroke Volume - drug effects | Antineoplastic Agents - therapeutic use | Biomarkers - blood | Heart Failure - blood | Neoplasms - drug therapy | Antimitotic agents | Care and treatment | Antineoplastic agents | Biological markers | Health aspects | Cancer | Cancer therapies | Heart diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function
by Rota, Marcello and Padin-Iruegas, M Elena and Misao, Yu and De Angelis, Antonella and Maestroni, Silvia and Ferreira-Martins, João and Fiumana, Emanuela and Rastaldo, Raffaella and Arcarese, Michael L and Mitchell, Thomas S and Boni, Alessandro and Bolli, Roberto and Urbanek, Konrad and Hosoda, Toru and Anversa, Piero and Leri, Annarosa and Kajstura, Jan
Circulation Research, ISSN 0009-7330, 07/2008, Volume 103, Issue 1, pp. 107 - 116
Ischemic heart disease is characterized chronically by a healed infarct, foci of myocardial scarring, cavitary dilation, and impaired ventricular performance.... 
Cardiac stem cells | Chronic myocardial infarct | Cardiac repair | RECRUITMENT | STEM-CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | cardiac repair | MULTIPOTENT | BONE-MARROW-CELLS | ISCHEMIC-HEART | cardiac stem cells | REGENERATE | chronic myocardial infarct | GROWTH | TISSUE INHIBITOR | PERIPHERAL VASCULAR DISEASE | CHEMOKINE | DIFFERENTIATION | HEMATOLOGY | Insulin-Like Growth Factor I - pharmacology | Cicatrix - etiology | Humans | Ventricular Dysfunction - etiology | Hepatocyte Growth Factor - pharmacology | Stem Cells - metabolism | Transplantation, Homologous | Cicatrix - metabolism | Heart Failure - therapy | Myocardial Infarction - therapy | Diploidy | Myocardial Infarction - pathology | Myocardium - metabolism | Cicatrix - therapy | Ventricular Dysfunction - metabolism | Collagenases - biosynthesis | Ventricular Dysfunction - pathology | Ventricular Dysfunction - therapy | Rats | Myocardium - pathology | Heart Failure - metabolism | Heart Failure - pathology | Myocardial Infarction - metabolism | Hepatocyte Growth Factor - metabolism | Cell Movement - drug effects | Collagen - metabolism | Myocardial Infarction - complications | Myocytes, Cardiac - pathology | Regeneration - drug effects | Stem Cell Transplantation - methods | Animals | Myocytes, Cardiac - metabolism | Stem Cells - pathology | Cicatrix - pathology | Hemodynamics | Chronic Disease | Insulin-Like Growth Factor I - metabolism | cardiac-repair | chronic-myocardial-infarct | cardiac-stem-cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Use of Amino-Terminal Pro–B-Type Natriuretic Peptide to Guide Outpatient Therapy of Patients With Chronic Left Ventricular Systolic Dysfunction
by Januzzi, James L., MD and Rehman, Shafiq U., MD and Mohammed, Asim A., MD and Bhardwaj, Anju, MD and Barajas, Linda, RN and Barajas, Justine and Kim, Han-Na, MD, MPH and Baggish, Aaron L., MD and Weiner, Rory B., MD and Chen-Tournoux, Annabel, MD and Marshall, Jane E., RDCS and Moore, Stephanie A., MD and Carlson, William D., MD and Lewis, Gregory D., MD and Shin, Jordan, MD and Sullivan, Dorothy, ANP and Parks, Kimberly, DO and Wang, Thomas J., MD and Gregory, Shawn A., MD and Uthamalingam, Shanmugam, MD and Semigran, Marc J., MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 58, Issue 18, pp. 1881 - 1889
Objectives The aim of this study was to evaluate whether chronic heart failure (HF) therapy guided by concentrations of amino-terminal pro–B-type natriuretic... 
Cardiovascular | Internal Medicine | heart failure | natriuretic peptides | outcomes | SURVIVAL | CHRONIC HEART-FAILURE | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | BNP | CARE | PREDICTION | TRIAL | CARVEDILOL | Prospective Studies | Standard of Care | Humans | Middle Aged | Kaplan-Meier Estimate | Treatment Outcome | Heart Failure - blood | Ambulatory Care | Heart Failure - therapy | Ventricular Dysfunction, Left - therapy | Ventricular Dysfunction, Left - blood | Peptide Fragments - blood | Ultrasonography | Quality of Life | Female | Aged | Heart Failure - diagnostic imaging | Chronic Disease | Natriuretic Peptide, Brain - blood | Heart failure | Care and treatment | Cardiology | Natriuretic peptides | Usage | Heart attacks | Peptides | Ischemia | Mortality | Diuretics | Hospitalization | Drug therapy | Acute coronary syndromes | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Electromechanical Dyssynchrony and Resynchronization of the Failing Heart
by Kirk, Jonathan A and Kass, David A
Circulation Research, ISSN 0009-7330, 08/2013, Volume 113, Issue 6, pp. 765 - 776
Patients with heart failure and decreased function frequently develop discoordinate contraction because of electric activation delay. Often termed... 
molecular biology | cell physiological phenomena | heart failure | cardiac resynchronization therapy | myocyte | ventricular function | LEFT-VENTRICULAR DYSSYNCHRONY | CARDIAC & CARDIOVASCULAR SYSTEMS | PACING SITE | LONG-TERM SURVIVAL | DILATED CARDIOMYOPATHY | DEVICE-BASED THERAPY | MYOCARDIAL GENE-EXPRESSION | CARDIAC-RHYTHM ABNORMALITIES | BUNDLE-BRANCH BLOCK | ASSOCIATION TASK-FORCE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | MECHANICAL DYSSYNCHRONY | Heart Failure - therapy | Ventricular Dysfunction - therapy | Humans | Heart Failure - physiopathology | Heart Failure - metabolism | Cardiac Resynchronization Therapy | Ventricular Dysfunction - physiopathology | Ventricular Dysfunction - metabolism | biventricular pacing | dyssynchrony | cell physiology | pathobiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights